Brussels, 29 October 2026 - EuropaBio welcomes PRONAV Clinical as its newest Associate Member.

Based in Ireland, PRONAV Clinical provides early-phase clinical trial supply services to emerging biotech innovators. The company supports clients in managing, de-risking and executing early-stage clinical supply chains on a global basis.

Drawing on its experience in clinical supply management, PRONAV Clinical brings practical expertise that may be valuable to emerging biotech companies and looks forward to sharing this knowledge with fellow EuropaBio members.

By joining EuropaBio, PRONAV Clinical aims to gain first-hand insight into the development and implementation of the European Biotech Act while increasing its visibility and integration within the European biotechnology ecosystem. The company also looks forward to contributing to the growth of the biopharmaceutical industry in Europe, particularly in Ireland, and supporting clinical development.

Dr. Claire Skentelbery, Director General of EuropaBio, said: “We are delighted to welcome Jim and the team into EuropaBio. We have a shared mission to see European clinical trials and supply chains working for patients and innovators and look forward to a busy year!”

Jim Kernan, CEO of PRONAV Clinical, said: “We’re delighted to be joining EuropaBio, it’s a great opportunity to learn from Europe’s vibrant biotech community, make new connections and contribute wherever we can. We’re excited to be part of it.”